A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 30 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

In the media

In the media

Read how the global media covers how pharmaceutical companies respond to market trends and global health issues using the Foundation's research, and translates the complexity of access to medicine for the public.

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

23 Feb 2021

Dozens of institutional investors push for ‘fair and equitable’ Covid-19 response

Ed Silverman of Stat News covers investors' call to action for equitable access to COVID-19 treatments and vaccines. 

23 Feb 2021

Asset managers call for ‘fair and equitable’ global efforts to end pandemic

Natalie Kenway for ESG Clarity writes about nearly 150 global investors' call to action for equitable access to COVID-19 treatments and vaccines....

23 Feb 2021

Global petition to help third world countries get medical resources to fight COVID

Glenda Korporaal for the Australian Business Network writes about investors' call to action for equitable access to COVID-19 treatments and vaccines.&...

23 Feb 2021

Daily ESG Briefing: Investors unite to call for fair access to Covid vaccines

Dominic Webb for Responsible Investor includes investors' call for equitable COVID-19 treatments and vaccines in a daily roundup of global ESG news.&n...

23 Feb 2021

Des fonds d’investissement exigent des vaccins pour tous

This article for Swiss newspaper Le Temps covers the Access to Medicine Foundation's partnership with nearly 150 investors to call for equitable acces...

15 Feb 2021

Rättvis tillgång på läkemedel bidrar till hållbar tillväxt

In this article in Swedish newspaper Aktuell Hållbarhet, institutional investors Alecta and SEB Investment Management outline their engagement with co...

10 Feb 2021

Global collaboration is the world’s best shot at ending the pandemic – here’s what Big Pharma can do

In a viewpoint for the Telegraph, Dag-Inge Ulstein, Minister of International Development for the Norwegian Government, and John-Arne R...

09 Feb 2021

4 principles for urgent pharma action to combat COVID-19

Drawing on the findings from the 2021 Access to Medicine Index, the Norwegian government, which co-chairs the Facilitation Council of the ACT-Accelera...

04 Feb 2021

Can Novartis really make its medicines available to everyone?

Writing for Swissinfo, Jessica Davis Plüss asks whether Switzerland-based Novartis's "experiment" to make its products widely available will succeed,...

30 Jan 2021

【国際】医薬品アクセスインデックス2021、首位GSK。上位企業がさらに躍進。下位との差開

Sustainable Japan, a Japanese news site on sustainability and ESG Investment, presents the ranking of the 2021 Access to Medicine Index, pointing to t...

29 Jan 2021

Het vaccin

In an interview with Cecile van Els, Art Rooijakkers cites the recent research from the 2021 Access to Medicine Index and highlights the key find...

28 Jan 2021

Report spotlights drug firms' supply chain initiatives, hurdles in LMICs

Liana Matt McLernon of the Center for Infectious Disease Research and Policy (CIDRAP) writes about the supply chain and manufacturing initiatives asse...

28 Jan 2021

Drugmakers 'inching ahead' in increasing access to drugs worldwide, with GlaxoSmithKline leading the pack

Nicole DeFeudis of Endpoints News writes about the 2021 Access to Medicine Index findings on how the pharmaceutical industry is 'inching ahead' in imp...

27 Jan 2021

Pharma is only ‘inching forward’ in boosting access to medicines in low-income countries

Ed Silverman for STAT refers to the slow progress reported in the 2021 Access to Medicine Index in broadening access to medicines despite the recent m...

27 Jan 2021

With focus on Covid-19, there is little preparedness for next pandemic: Access to Medicine Foundation

Reporting on the 2021 Access to Medicine Index for The Hindu Business Line, PT Jyothi Datta focuses on the spike of research into COVID-19 treatments...

27 Jan 2021

Access to Medicine and COVID-19

Writing for Pharma Times, Jayasree K. Iyer reports on the findings of the 2021 Access to Medicine Index and describes how the COVID-19 has put the pha...

Get in touch

Back to top |